If you’re on the fence about investing in Grifols, S.A. or Amarin Corporation plc because ... Further, it develops Xembify Pre-filled syringes, Gamunex Bags, and FlexBag; Xembify Biweekly dosing, ...

Despite the market punishing Grifols, we believe that this presents a buying opportunity. Click here for our investment ...

Grifols shares were up 4.4% at 8.49 euros ($9.18) after gaining 12% earlier in the day. The blue-chip IBEX35 index was down 0.1%. In its stock market filing, Brookfield said it maintained "a ...

Canadian investment fund Brookfield (NYSE:BAM) resumed talks on a potential takeover of Spanish pharmaceuticals company Grifols (NASDAQ:GRFS), El Confidencial reported on Wednesday, citing ...

MADRID, April 2 (Reuters) - Shares in Spanish pharmaceutical company Grifols rose on Wednesday after Canadian fund Brookfield said it was talking with shareholders, following a report from website ...

Noida: Child PGI in the city is set to launch a pilot project to deliver blood bags to nearby hospitals using drone technology. The initiative, which already received approval from the ...

Much like the case within pharmacies, labelling also plays a crucial role here in helping to ensure that each bag of blood is accurately labelled and matched to the correct recipient/patient. One way ...

As per MRFR analysis, the Blood Platelets Market Growth Size was estimated at 6.08 (USD Billion) in 2023. US, NY, UNITED STATES, April 21, 2025 /EINPresswire / -- The blood platelets market has ...

In its first-quarter 2025 investor letter, White Falcon Capital Management highlighted stocks such as Grifols, S.A. (NASDAQ:GRFS). Grifols, S.A. (NASDAQ:GRFS) is a plasma therapeutic company.

Grifols and Brookfield said they aren't in takeover talks, after a media report indicated the investment company had resumed discussions with the Grifols family--which controls the Spanish ...

IBL International GmbH, a Tecan company, which develops, manufactures and offers specialty diagnostics, today announced a strategic partnership with Grifols, a global healthcare company and ...

IBL International has entered a strategic collaboration with healthcare company Grifols to develop biomarker panels for speciality diagnostics. Through this partnership, IBL will develop the ...